Study on colon-specific 5-Fu pH-enzyme Di-dependent chitosan microspheres.

Colon-specific drug delivery systems (CDDS) can improve the bioavailability of drug through the oral route. A novel formulation for oral administration using pH-enzyme Di-dependent chitosan mcirospheres (MS) and 5-Fu as a model drug has been investigated for colon-specific drug delivery by the emulsification/chemical cross-linking and coating technique, respectively. The influence of polymer concentration, ratio of drug to polymer, the amount of crosslinking agent and the stirring speed on the encapsulation efficiency, particle size in microspheres were evaluated. The best formulation was optimized by an orthogonal design. Drug release studies under conditions mimicking stomach to colon transit have shown that the drug was protected from being released in the physiological environment of the stomach and small intestine. The plasma concentrations of 5-Fu after oral administration of coated chitosan MS to rats were determined and compared with that of 5-Fu solution. The in vivo pharmacokinetics study of 5-Fu loaded pH-enzyme Di-dependent chitosan MS showed sustained plasma 5-Fu concentration-time profile. The in vitro release correlated well with the pharmacokinetics profile. The results clearly demonstrated that the pH-enzyme Di-dependent chitosan MS is potential system for colon-specific drug delivery of 5-Fu.

[1]  G. Golomb,et al.  Preparation and evaluation of chitosan microspheres containing bisphosphonates. , 1997, Journal of drug targeting.

[2]  Y. Y. Yang,et al.  Effects of inner water volume on the peculiar surface morphology of microspheres fabricated by double emulsion technique. , 2001, Journal of microencapsulation.

[3]  R. Hahn,et al.  A double‐blind comparison of intensive course 5‐fluorouracil by oral vs. intravenous route in the treatment of colorectal carcinoma , 1975, Cancer.

[4]  D. Attwood,et al.  An in vivo investigation into the suitability of pH dependent polymers for colonic targeting , 1993 .

[5]  K. Chong-Kook,et al.  Preparation and evaluation of sustained release microspheres of terbutaline sulfate , 1994 .

[6]  Robert B. Diasio,et al.  Clinical Pharmacology of 5-Fluorouracil , 1989, Clinical pharmacokinetics.

[7]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[8]  Tejraj M Aminabhavi,et al.  Recent advances on chitosan-based micro- and nanoparticles in drug delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[9]  S. Haupt,et al.  The colon as a possible target for orally administered peptide and protein drugs. , 2002, Critical reviews in therapeutic drug carrier systems.

[10]  K. Gupta,et al.  Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman. , 2006, Carbohydrate research.

[11]  S. Şenel,et al.  Potential applications of chitosan in veterinary medicine. , 2004, Advanced drug delivery reviews.

[12]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .

[13]  R. Kaushik,et al.  Chitosan microspheres as a potential carrier for drugs. , 2004, International journal of pharmaceutics.

[14]  P. Sinko,et al.  Pharmacokinetics of Orally Administered Camptothecins , 2000, Annals of the New York Academy of Sciences.

[15]  T. Aminabhavi,et al.  Formulation and in-vitro evaluation of novel starch-based tableted microspheres for controlled release of ampicillin , 2008 .

[16]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[17]  Eugene Khor,et al.  Implantable applications of chitin and chitosan. , 2003, Biomaterials.

[18]  L. Xie,et al.  Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[19]  M. N. R. Kumar.  A review of chitin and chitosan applications , 2000 .

[20]  B. Lu,et al.  Novel colon-specific microspheres with highly dispersed hydroxycamptothecin cores: their preparation, release behavior, and therapeutic efficiency against colonic cancer. , 2006, Journal of pharmaceutical sciences.

[21]  A. Jayakrishnan,et al.  Progesterone-loaded chitosan microspheres: a long acting biodegradable controlled delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[22]  J. Mano,et al.  Chitosan-Based Particles as Controlled Drug Delivery Systems , 2004, Drug delivery.

[23]  P. Sinko,et al.  Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[24]  A. Lamprecht,et al.  Oral bioavailability of a low molecular weight heparin using a polymeric delivery system. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[25]  G. Ponchel,et al.  An original method for studying in vitro the enzymatic degradation of cross-linked starch microspheres. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Iqbal,et al.  Starch capsules: an alternative system for oral drug delivery. , 2000, Pharmaceutical science & technology today.

[27]  Makarand V Risbud,et al.  Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. , 2005, Biomaterials.